Wikidata

(Q63573491)

English

An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy (TOPAZ)

clinical trial

In more languages

Statements

short name
TOPAZ (English)
0 references
title
Phase 2 Active Treatment Study to Evaluate the Efficacy and Safety of SRK-015 in Patients With Later-Onset Spinal Muscular Atrophy (TOPAZ) (English)
0 references
medical condition
atrophy
0 references
muscular atrophy
0 references
start time
22 April 2019
0 references
end time
January 2021
0 references
number of participants
55
0 references
minimum age
2 year
0 references
maximum age
21 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63573491&oldid=1857262447"